BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10423525)

  • 1. Preparation of HIV TAR RNA with RNA scissors.
    Wyszko E; Fuerste JP; Barciszewska M; Szymanski M; Adamiak R; Erdmann VA; Barciszewski J
    J Biochem; 1999 Aug; 126(2):326-32. PubMed ID: 10423525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure.
    Delling U; Reid LS; Barnett RW; Ma MY; Climie S; Sumner-Smith M; Sonenberg N
    J Virol; 1992 May; 66(5):3018-25. PubMed ID: 1560535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.
    Neenhold HR; Rana TM
    Biochemistry; 1995 May; 34(19):6303-9. PubMed ID: 7756257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of HIV-1 TAR variants by the Tat protein.
    Marozzi A; Meneveri R; Giacca M; Gutierrez MI; Siccardi AG; Ginelli E
    J Biotechnol; 1998 Apr; 61(2):117-28. PubMed ID: 9654745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
    Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
    Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1.
    Yamamoto R; Toyoda S; Viljanen P; Machida K; Nishikawa S; Murakami K; Taira K; Kumar PK
    Nucleic Acids Symp Ser; 1995; (34):145-6. PubMed ID: 8841594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein.
    Wang DY; Sen D
    Comb Chem High Throughput Screen; 2002 Jun; 5(4):301-12. PubMed ID: 12052181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
    Wu-Baer F; Sigman D; Gaynor RB
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7153-7. PubMed ID: 7638159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozyme targeting of HIV-1 LTR.
    Ventura M; Wang P; Franck N; Saragosti S
    Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM; Jeang KT
    Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.